The iconic rise of Viagra has long been a example of pharmaceutical success, yet its future within the broader market now presents questions about long-term gains. Generic versions are undercutting patent protection , prompting anxieties that investing in companies closely tied to Viagra's previous standing could be a dangerous decision , especiall